Abstract
Candida norvegensis has been an unusual cause of infections in humans. In Norway this species was isolated from eight patients from 1990 to 1996 and was of probable pathogenic significance in four of them. All isolates were resistant to fluconazole. The same was true for two C. norvegensis isolates from before 1940, and it is therefore assumed that the fluconazole resistance is inherent.
Full Text
The Full Text of this article is available as a PDF (107.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cormican M. G., Pfaller M. A. Standardization of antifungal susceptibility testing. J Antimicrob Chemother. 1996 Oct;38(4):561–578. doi: 10.1093/jac/38.4.561. [DOI] [PubMed] [Google Scholar]
- DIETRICHSON E. Etude d'une collection norvegienne de levures. Ann Parasitol Hum Comp. 1954;29(4):460–concl. [PubMed] [Google Scholar]
- Hood S. V., Moore C. B., Denning D. W. Isolation of Candida norvegensis from clinical specimens: four case reports. Clin Infect Dis. 1996 Nov;23(5):1185–1187. doi: 10.1093/clinids/23.5.1185. [DOI] [PubMed] [Google Scholar]
- Nielsen H., Stenderup J., Bruun B., Ladefoged J. Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1990 Jul;28(7):1664–1665. doi: 10.1128/jcm.28.7.1664-1665.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nielsen H., Stenderup J. Invasive Candida norvegensis infection in immunocompromised patients. Scand J Infect Dis. 1996;28(3):311–312. doi: 10.3109/00365549609027180. [DOI] [PubMed] [Google Scholar]
- Pfaller M. A., Barry A. L. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol. 1994 Aug;32(8):1992–1996. doi: 10.1128/jcm.32.8.1992-1996.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]